{
}
UBS has lowered its price target for Qiagen NV to $48 from $50 while maintaining a Neutral rating. The Netherlands-based company specializes in Sample to Insight solutions, which transform biological samples into molecular insights through integrated technologies for DNA, RNA, and protein analysis. Its offerings include sample preparation, assay technologies, bioinformatics, and automation platforms that enhance molecular testing workflows.
QIAGEN NV, a Netherlands-based holding company, specializes in Sample to Insight solutions that convert biological samples into molecular insights. Their offerings include technologies for isolating DNA, RNA, and proteins, alongside analysis and bioinformatics solutions that enhance molecular testing workflows. The company utilizes automation platforms based on PCR and next-generation sequencing to streamline these processes.
QIAGEN NV, a Netherlands-based holding company, specializes in transforming biological samples into molecular insights through its Sample to Insight solutions. These solutions encompass sample and assay technologies, bioinformatics, and automation systems, facilitating the isolation and analysis of DNA, RNA, and proteins from various sources. The company's platforms integrate polymerase chain reaction (PCR) and next-generation sequencing (NGS) to streamline molecular testing workflows.
Priya Pandey, a biotechnology graduate, excels in creating engaging content across various industries, including healthcare and technology. Coherent Market Insights offers comprehensive market intelligence and consulting services, providing detailed reports on sectors like food and beverages and pharmaceuticals, with insights into market dynamics and competitive strategies. The latest report on the Lateral Flow Assay Market forecasts trends and growth from 2024 to 2031, analyzing consumer behavior and regulatory factors while highlighting key players and emerging opportunities.
UBS has maintained a "Neutral" rating on Qiagen with a target price of 50 euros, following the company's quarterly report that showed strong organic sales growth in diagnostics. However, concerns linger over a slower recovery in the biopharma sector and doubts about Qiagen's ability to match competitors' growth rates.In other news, Hedy Lamarr, celebrated for her Hollywood career, is also recognized for her contributions to technology, particularly in Wi-Fi and Bluetooth. Meanwhile, Rainer Mellis has resigned as CEO of Volksbank Düsseldorf Neuss amid a fraud case, and Australia is advancing legislation to restrict social media access for those under 16.
QIAGEN NV
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs lowers qiagen price target to forty eight maintains neutral rating
17:23 07.02.2025
qiagen nv maintains neutral rating as it advances molecular insights solutions
07:21 06.02.2025
qiagen nv enhances molecular insights with integrated sample to insight solutions
07:14 06.02.2025
lateral flow assay market analysis trends and growth opportunities 2024 to 2031
United States Dollar
QuidelOrtho Corporation
Hologic Inc
Thermo Fisher Scientific Inc.
QIAGEN NV
Siemens AG
Abcam plc
PerkinElmer Inc
Danaher Corporation
Eiken Chemical Co., Ltd.
Becton, Dickinson and Company
Merck KGaA
Bio-Rad Laboratories Inc
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Biomerieux SA
FRA
ARG
NZL
CAN
TUR
SAU
ARE
USA
RUS
IND
AUS
ESP
GBR
SGP
BRA
IRN
CHN
DEU
MEX
ITA
JPN
Priya Pandey
Show more
09:06 10.01.2025
ubs maintains neutral rating on qiagen with target price of 50 euros
Euro
Volksbank Düsseldorf Neuss eG
Euronext N.V.
QIAGEN NV
UBS AG
Deutsche Börse AG
CDUrack UG
AUS
CHE
DEU
Dan Leonard
Friedrich Merz
Rainer Mellis
Show more
07:25 07.11.2024
Trending
Subcategory
Industry Trends
Corporate News
Startups & Entrepreneurship
Supply Chain Management
Stock Market Updates
AI Innovations
Global Trade Developments
Government Economic Policies
Banking Regulations
Funding Rounds & Investments
Retail and Consumer Goods
Industry Mergers & Acquisitions
Global Financial Events
CEO Changes
Government Policies
Workplace Trends
Cryptocurrency Trends
Economic Sanctions
Decentralized Finance (DeFi) Innovations
Inflation and Monetary Impact
Countries:
Companies:
NVIDIA Corporation
Tesla, Inc.
Google Inc.
Apple Inc.
TENCENT
Microsoft Corporation
SpaceXCoin USD
Amazon.com, Inc.
Tesmec S.p.A.
Tally Solutions Ltd.
Vanguard S&P 500 ETF
Liechtensteinische Landesbank Aktiengesellschaft
Banco Santander, S.A.
BNP Paribas SA
UniCredit S.p.A.
CATLOKI USD
Credit Suisse Real Estate Fund Siat
Raiffeisen Bank International AG
VeriSign, Inc.
Berkshire Hathaway Inc.
Currencies:
United States Dollar
Indian Rupee
Swiss Franc
Euro
Chinese Yuan
United Arab Emirates Dirham
British Pound Sterling
Saudi Riyal
Qatari Riyal
Japanese Yen
Singapore Dollar
Kuwaiti Dinar
Offshore Chinese Yuan
Azerbaijani Manat
New Taiwan Dollar
People: